Related Experiment Video
Updated: Sep 26, 2025

04:22
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
1.0K
Somatic genomic changes in single Alzheimer's disease neurons
Michael B Miller1,2,3,4, August Yue Huang2,3,4, Junho Kim2,3,4,5
1Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Nature
|April 21, 2022
Summary
Alzheimer's disease (AD) accelerates somatic DNA alterations in neurons, distinct from normal aging. These genomic changes, potentially driven by oxidative stress, contribute to neurodegeneration and neuronal dysfunction in AD.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Alzheimer's disease (AD) is characterized by neurodegeneration, but the underlying causes of neuronal dysfunction and death are not fully understood.
- Neurons accumulate somatic mutations during normal aging, influenced by genetic and environmental factors.
- Understanding these mutations is crucial for deciphering AD pathogenesis.
Purpose of the Study:
- To investigate somatic DNA alterations in neurons from individuals with and without Alzheimer's disease.
- To identify distinct mutational patterns associated with AD.
- To explore the mechanisms driving genomic damage in AD neurons.
Main Methods:
- Single-cell whole-genome sequencing of 319 neurons from the prefrontal cortex and hippocampus.
- Analysis of somatic DNA alterations in neurons from Alzheimer's disease patients and neurotypical controls.
- In situ assessment of nucleotide oxidation in affected neurons.
Main Results:
- Neurons in Alzheimer's disease exhibit increased somatic DNA alterations compared to controls, with distinct molecular patterns (signature C) beyond age-related changes (signature A).
- Signature C involves specific nucleotide changes (e.g., C>A), suggesting a role for nucleotide oxidation, which was observed to be increased in AD neurons.
- Mutations affect coding regions, potentially leading to dysfunctional cells and proteostatic stress, with evidence suggesting transcription-coupled repair involvement.
Conclusions:
- Alzheimer's disease pathogenesis involves aberrant accumulation of DNA alterations in neurons, contributing to neurodegeneration.
- Genomic damage, potentially mediated by oxidative stress and influenced by transcription, plays a significant role in neuronal dysfunction and death in AD.
- These findings offer new insights into the molecular cascade of Alzheimer's disease development.
Related Concept Videos
Alzheimer's Disease: Overview
696
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
696
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Alzheimer's Disease: Treatment
272
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
272

